Nigella sativa

Study Reveals Proprietary Black Seed Oil Positively Influences Immunity & Well-being in High-Stress Physical Conditions

Retrieved on: 
Tuesday, January 31, 2023

The randomized, double-blind, placebo-controlled study published in Food Science & Nutrition Research suggests that mediation with ThymoQuin®, through the Gut-Immune-Axis, can have a significant positive impact.

Key Points: 
  • The randomized, double-blind, placebo-controlled study published in Food Science & Nutrition Research suggests that mediation with ThymoQuin®, through the Gut-Immune-Axis, can have a significant positive impact.
  • Stress-related immune changes can be significant for health, including a heightened vulnerability to infections and a decreased immune system.
  • The study examined the potential effect of the proprietary black seed oil, ThymoQuin®, through dietary supplementation for one month, then using subjective and objective measures, the researchers tracked the results on the immune system and overall well-being.
  • The study included experienced marathon runners who consumed 500mg daily of black cumin seed oil (ThymoQuin®) or a placebo oil for four weeks.

Study Reveals a Proprietary Black Seed Oil Positively Influences Immunity & Well-being in High-Stress Physical Conditions

Retrieved on: 
Thursday, December 15, 2022

Stress-related immune changes can be significant for health, including a heightened vulnerability to infections and a decreased immune system.

Key Points: 
  • Stress-related immune changes can be significant for health, including a heightened vulnerability to infections and a decreased immune system.
  • Exercise-induced stress can impact the immune system of endurance athletes by increasing upper-respiratory tract complaints and lower mood states.
  • The study examined the potential effect of the proprietary black seed oil, ThymoQuin®, through dietary supplementation for one month, then using subjective and objective measures, the researchers tracked the results on the immune system and overall well-being.
  • The study included experienced marathon runners who consumed 500mg daily of black cumin seed oil (ThymoQuin®) or a placebo oil for four weeks.

New study reveals ThymoQuin® with Omega-3 Aids in Sports Immunity & Wellbeing

Retrieved on: 
Wednesday, October 12, 2022

The study results showed that the athlete participants had improved immune systems and overall mental well-being.

Key Points: 
  • The study results showed that the athlete participants had improved immune systems and overall mental well-being.
  • Stress-related gut imbalances and immune changes can represent significant challenges for athletes exercise performance and overall health and well-being.
  • In the study, researchers used the exercise stress of endurance running to challenge gut microbiome resilience and temporarily suppress immune vigilance.
  • To learn more about ThymoQuin, visit TriNutra.com or contact TriNutras exclusive U.S. distribution partner, Barrington Nutritionals .

New Bulletin on Nigella Seed and Seed Oil Adulteration Published by ABC-AHP-NCNPR Botanical Adulterants Prevention Program

Retrieved on: 
Tuesday, October 4, 2022

AUSTIN, Texas, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) has issued a Botanical Adulterants Prevention Bulletin (BAPB) on nigella (Nigella sativa) seed and seed oil.

Key Points: 
  • AUSTIN, Texas, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) has issued a Botanical Adulterants Prevention Bulletin (BAPB) on nigella (Nigella sativa) seed and seed oil.
  • It summarizes the available scientific data on nigella seed and seed oil adulteration and analytical methods to detect adulteration, and provides information about the botany, uses, supply chain/value network, and market of the botanical.
  • The nigella seed and seed oil BAPB is the 26th bulletin and the 75th peer-reviewed publication published by BAPP.
  • To date, BAPP has published 75 extensively peer-reviewed articles, including Botanical Adulterants Prevention Bulletins, Laboratory Guidance Documents, and Botanical Adulterants Monitor e-newsletters.

Therapeutic Solutions International Discusses Claims of Possible COVID-19 Suppressive Activity of QuadraMune™ Ingredients by Independent Universities Made After Patent Filing

Retrieved on: 
Monday, September 27, 2021

On May 5th, 2020, Therapeutic Solutions International publicly announced their production and patent filing's for QuadraMune, a nutraceutical developed with the aim of naturally modulating susceptibility, immunity, and inflammation in the context of COVID-191.

Key Points: 
  • On May 5th, 2020, Therapeutic Solutions International publicly announced their production and patent filing's for QuadraMune, a nutraceutical developed with the aim of naturally modulating susceptibility, immunity, and inflammation in the context of COVID-191.
  • Following TSOI's initial research, there have been multiple studies published in peer-reviewed journals by independent academic institutions supporting the individual ingredients in QuadraMune, which are listed below by ingredients.
  • To our knowledge, QuadraMune is the only nutraceutical on the market with this level of independent scientific support for its potential use in COVID-19.
  • Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.

Novatek Pharmaceuticals Initiates A Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study Of Its Oral Drug, TQ Formula, Against Novel Coronavirus 2019 (COVID-19) In The Outpatient Setting

Retrieved on: 
Friday, August 13, 2021

HOUSTON, Aug. 12, 2021 /PRNewswire/ -- Novatek Pharmaceuticals, INC announced today that the company received FDA approval for its investigational new drug (IND) study; Phase 2 clinical trial for its oral drug, TQ Formula, against Novel Coronavirus 2019 (COVID-19) in the outpatient setting.

Key Points: 
  • HOUSTON, Aug. 12, 2021 /PRNewswire/ -- Novatek Pharmaceuticals, INC announced today that the company received FDA approval for its investigational new drug (IND) study; Phase 2 clinical trial for its oral drug, TQ Formula, against Novel Coronavirus 2019 (COVID-19) in the outpatient setting.
  • The study is currently enrolling patients, with 16 out of 60 patients already randomized with no reported serious adverse events (SAEs) reported, to-date.
  • This is a randomized, double-blind, placebo-controlled phase II study where participants will be randomized 1:1 and will receive up to 14 days of oral dosing.
  • TQ Formula is an oral GMP-manufactured drug, which represents a concentrated enteric-coated formulation of Nigella Sativa oil, with higher than average thymoquinone concentration.

Dr. Dima Ali Announces DermaDeal Act, Offering Her Skincare Products Free of Charge

Retrieved on: 
Thursday, April 9, 2020

RESTON, Va., April 9, 2020 /PRNewswire/ --In an effort to help disseminate information about the healing properties of Nigella Sativa, Dr. Dima is offering her COSMINOLOGY skincare products FREE OF CHARGE while supplies last.

Key Points: 
  • RESTON, Va., April 9, 2020 /PRNewswire/ --In an effort to help disseminate information about the healing properties of Nigella Sativa, Dr. Dima is offering her COSMINOLOGY skincare products FREE OF CHARGE while supplies last.
  • Dr. Dima wants to share her professional expertise, personal opinions and positive energy with everyone through her DermaDeal Act.
  • Dr. Dima Ali has been practicing Aesthetic and Anti-Aging Medicine in Northern Virginia at Wellmedica for over 20 years.
  • Details of the DermaDeal Act:
    How to claim: Visit WWW.COSMINOLOGY.COM , select one (1) of the COSMINOLOGY products listed above and follow directions to check out.